On October 15, 2020 F. Hoffmann-La Roche Ltd. (hereafter "Roche") [Head Office: Basel, Switzerland. CEO: Severin Schwan] reported its third quarter sales 2020 (January 1 – September 30, 2020) (Press release, Chugai, OCT 15, 2020, View Source [SID1234568500]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Roche owns 59.89% of Chugai’s outstanding shares (61.17% of the total number of shares issued excluding treasury stock) as of the end of September 2020.

Its press release and presentation materials can be found on its website (View Source).
Chugai’s performance for the period of January 1 to September 30, 2020 is included in the announced Roche Group’s results.